Could your own bone marrow cells heal a damaged liver?
NCT ID NCT07374185
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early trial tests whether a patient's own bone marrow cells, mixed with growth factors, can help treat liver cirrhosis. Ten adults with cirrhosis (but no active cancer or severe infection) will receive the cells through an IV. The main goal is to see if the treatment improves liver function scores.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- patient's own bone marrow cells combined with growth factors
- What this could lead to
- If it works, this could point toward a way to improve liver function in cirrhosis patients without needing a transplant.
- What could go wrong
- This is a very small early trial with only 10 people, so results may not apply widely. The treatment involves a procedure and carries risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Capital Private Hospital Alrabee Street
Baghdad, Iraq, 964, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist